A detailed history of Citigroup Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 186,173 shares of IRWD stock, worth $392,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186,173
Previous 184,668 0.81%
Holding current value
$392,825
Previous $1.2 Million 36.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.93 - $7.04 $5,914 - $10,595
1,505 Added 0.81%
186,173 $765,000
Q2 2024

Aug 12, 2024

SELL
$5.58 - $8.61 $4.26 Million - $6.57 Million
-763,042 Reduced 80.51%
184,668 $1.2 Million
Q1 2024

May 10, 2024

BUY
$8.32 - $15.45 $4.87 Million - $9.05 Million
585,710 Added 161.8%
947,710 $8.25 Million
Q4 2023

Feb 09, 2024

SELL
$8.79 - $11.51 $595,856 - $780,239
-67,788 Reduced 15.77%
362,000 $4.14 Million
Q3 2023

Nov 09, 2023

BUY
$8.25 - $11.35 $67,130 - $92,354
8,137 Added 1.93%
429,788 $4.14 Million
Q2 2023

Aug 10, 2023

SELL
$10.1 - $11.6 $1.63 Million - $1.87 Million
-161,276 Reduced 27.67%
421,651 $4.49 Million
Q1 2023

May 11, 2023

BUY
$10.37 - $12.56 $949,000 - $1.15 Million
91,514 Added 18.62%
582,927 $6.13 Million
Q4 2022

Feb 09, 2023

SELL
$9.9 - $12.43 $1.63 Million - $2.05 Million
-164,581 Reduced 25.09%
491,413 $6.09 Million
Q3 2022

Nov 10, 2022

BUY
$10.14 - $12.38 $2.55 Million - $3.11 Million
251,371 Added 62.12%
655,994 $6.8 Million
Q2 2022

Aug 10, 2022

BUY
$11.05 - $12.72 $3.43 Million - $3.95 Million
310,252 Added 328.76%
404,623 $4.67 Million
Q1 2022

May 12, 2022

SELL
$10.61 - $12.88 $3.42 Million - $4.15 Million
-322,112 Reduced 77.34%
94,371 $1.19 Million
Q4 2021

Feb 10, 2022

BUY
$10.86 - $13.95 $959,328 - $1.23 Million
88,336 Added 26.92%
416,483 $4.86 Million
Q3 2021

Nov 10, 2021

BUY
$11.92 - $13.92 $3.91 Million - $4.57 Million
328,147 New
328,147 $4.29 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $323M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.